No 'serious or severe' adverse effect following vaccination so far: Govt

Two men -- one each in Uttar Pradesh and Karnataka -- have died after they received COVID-19 jabs

coronavirus vaccine, covid vaccine, vaccination, coronavirus, covid 19
Jabalpur: A medic administers the first dose of Covishield vaccine to a frontline worker, after the launch of Covid-19 vaccination drive at Victoria Hospital in Jabalpur, Jan. 16, 2021. (PTI Photo)
Press Trust of India New Delhi
2 min read Last Updated : Jan 18 2021 | 11:28 PM IST

There has been "no case of serious or severe" adverse event following immunisation (AEFI) till date, the health ministry said on the third day of the COVID-19 vaccination drive on Monday.

Two men -- one each in Uttar Pradesh and Karnataka -- have died after they received COVID-19 jabs.

In a press conference, additional secretary in the health ministry Manohar Agnani said the man from Moradabad in Uttar Pradesh died due to cardiopulmonary disease. The death "is not related to vaccination as per the post-mortem report", he said.

The health worker who was vaccinated on January 16 and died the next evening.

Agnani further said that the cause of death of another man from Bellary in Karnataka is anterior wall infarction with cardiopulmonary failure.

The post-mortem of the man, who was vaccinated on January 16 and died on Monday, is scheduled to be conducted at Vijayanagar Institute of Medical Sciences in Bellary.

"No case of serious/severe AEFI attributable to vaccination till date," Agnani added.

A total of 3,81,305 beneficiaries have so far been vaccinated for COVID-19 and 580 adverse events following immunisation were reported in the country till now, the Union health ministry said on Monday.

Agnani said 1,48,266 beneficiaries were vaccinated across 25 states and Union territories till 5 pm on Monday.

He said a cumulative 580 adverse events following immunisation (AEFI) and seven cases of hospitalisation have so far been reported in the country since the nationwide COVID-19 inoculation drive began on January 16.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineCentre

First Published: Jan 18 2021 | 11:20 PM IST

Next Story